Panacea Life Sciences Holdings, Inc.

PLSHOTCHealthcare● Active

$0.03

+$0.00(+0.00%)

Market Cap$679161

P/E Ratio—

52W High$0.1996

52W Low$0.0211

Avg Volume16K

Open$0.03

Beta2.68

Earnings Financials Revenue

Panacea Life Sciences Holdings, Inc. (PLSH) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

PLSH · earnings · updated Jun 15, 2026

Latest Earnings

Q2 FY2026Report Date: May 12, 2026

EPS Actual

-$0.06

Revenue

$0.00B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 12, 2026

After Market Close

PLSH reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 2, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away79

Expected DateSep 2, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	May 12, 2026	—	-$0.06	—	$0.00B	—	—
— Q1 FY2026	Mar 9, 2026	—	-$0.02	—	$0.00B	—	—
— Q4 FY2025	Nov 12, 2025	—	-$0.00	—	$0.00B	—	—
— Q3 FY2025	Aug 4, 2025	—	$0.09	—	$0.00B	—	—
— Q2 FY2025	May 14, 2025	—	-$0.00	—	$0.00B	—	—
— Q4 FY2024	Dec 31, 2024	—	$0.17	—	$0.00B	—	—
— Q4 FY2024	Nov 12, 2024	—	-$0.06	—	$0.00B	—	—
— Q3 FY2024	Aug 30, 2024	—	-$0.07	—	$0.00B	—	—

Q2 FY2026

May 12, 2026

EPS Actual

-$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2026

Mar 9, 2026

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2025

Nov 12, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2025

Aug 4, 2025

EPS Actual

$0.09

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2025

May 14, 2025

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2024

Dec 31, 2024

EPS Actual

$0.17

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2024

Nov 12, 2024

EPS Actual

-$0.06

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q3 FY2024

Aug 30, 2024

EPS Actual

-$0.07

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	May 12, 2026	—	$0.03	$0.03	+5.49%
— Q1 FY2026	Mar 9, 2026	—	$0.04	$0.05	+9.76%
— Q4 FY2025	Nov 12, 2025	—	$0.06	$0.06	+0.00%
— Q3 FY2025	Aug 4, 2025	—	$0.03	$0.03	+0.00%
— Q2 FY2025	May 14, 2025	—	$0.04	$0.04	+0.00%
— Q4 FY2024	Dec 31, 2024	—	$0.03	$0.03	-22.60%
— Q4 FY2024	Nov 12, 2024	—	$0.10	$0.10	+0.00%
— Q3 FY2024	Aug 30, 2024	—	$0.06	$0.06	+0.00%

Q2 FY2026+5.49%

Report Date

May 12, 2026

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q1 FY2026+9.76%

Report Date

Mar 9, 2026

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.05

Q4 FY2025+0.00%

Report Date

Nov 12, 2025

EPS Beat/Miss

—

Price Before

$0.06

Price After

$0.06

Q3 FY2025+0.00%

Report Date

Aug 4, 2025

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q2 FY2025+0.00%

Report Date

May 14, 2025

EPS Beat/Miss

—

Price Before

$0.04

Price After

$0.04

Q4 FY2024-22.60%

Report Date

Dec 31, 2024

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q4 FY2024+0.00%

Report Date

Nov 12, 2024

EPS Beat/Miss

—

Price Before

$0.10

Price After

$0.10

Q3 FY2024+0.00%

Report Date

Aug 30, 2024

EPS Beat/Miss

—

Price Before

$0.06

Price After

$0.06

Beat Rate0 / 8 quarters

Largest Move-22.60% (Q4 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Panacea Life Sciences Holdings, Inc. (PLSH) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.06 (in line with the analyst consensus of —). The next PLSH earnings date is expected around September 2, 2026.

Each quarter, investors track PLSH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PLSH revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

PLSH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

PLSH earnings · 4 questions

Panacea Life Sciences Holdings, Inc.'s next earnings report is expected around September 2, 2026. PLSH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PLSH historically reports after market close (AMC).

PLSH earnings datewhen is PLSH earningsPLSH next earnings datewhen does PLSH report earningsPLSH earnings calendar

▸ Source: FMP · Panacea Life Sciences Holdings, Inc. SEC filings · US GAAP · Panacea Life Sciences Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026